Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 2
1980 1
1981 3
1982 1
1983 1
1984 1
1985 1
1986 2
1988 1
1989 2
1990 2
1992 1
1993 1
1994 3
1995 2
1996 2
1997 1
2000 1
2001 1
2002 1
2003 1
2005 1
2007 1
2008 2
2009 1
2013 2
2014 1
2015 1
2016 1
2017 1
2019 1
2020 2
2021 3
2022 4
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
Masterful Antibodies: Checkpoint Blockade.
Lonberg N, Korman AJ. Lonberg N, et al. Cancer Immunol Res. 2017 Apr;5(4):275-281. doi: 10.1158/2326-6066.CIR-17-0057. Cancer Immunol Res. 2017. PMID: 28373215 Review.
An epitope-enriched immunogen expands responses to a conserved viral site.
Caradonna TM, Ronsard L, Yousif AS, Windsor IW, Hecht R, Bracamonte-Moreno T, Roffler AA, Maron MJ, Maurer DP, Feldman J, Marchiori E, Barnes RM, Rohrer D, Lonberg N, Oguin TH 3rd, Sempowski GD, Kepler TB, Kuraoka M, Lingwood D, Schmidt AG. Caradonna TM, et al. Among authors: lonberg n. Cell Rep. 2022 Nov 8;41(6):111628. doi: 10.1016/j.celrep.2022.111628. Cell Rep. 2022. PMID: 36351401 Free PMC article.
Engineering an Antibody V Gene-Selective Vaccine.
Ronsard L, Yousif AS, Peabody J, Okonkwo V, Devant P, Mogus AT, Barnes RM, Rohrer D, Lonberg N, Peabody D, Chackerian B, Lingwood D. Ronsard L, et al. Among authors: lonberg n. Front Immunol. 2021 Sep 9;12:730471. doi: 10.3389/fimmu.2021.730471. eCollection 2021. Front Immunol. 2021. PMID: 34566992 Free PMC article.
Engaging an HIV vaccine target through the acquisition of low B cell affinity.
Ronsard L, Yousif AS, Nait Mohamed FA, Feldman J, Okonkwo V, McCarthy C, Schnabel J, Caradonna T, Barnes RM, Rohrer D, Lonberg N, Schmidt A, Lingwood D. Ronsard L, et al. Among authors: lonberg n. Nat Commun. 2023 Aug 28;14(1):5249. doi: 10.1038/s41467-023-40918-2. Nat Commun. 2023. PMID: 37640732 Free PMC article.
Human antibodies from transgenic mice.
Lonberg N, Huszar D. Lonberg N, et al. Int Rev Immunol. 1995;13(1):65-93. doi: 10.3109/08830189509061738. Int Rev Immunol. 1995. PMID: 7494109 Review.
Human monoclonal antibodies from transgenic mice.
Lonberg N. Lonberg N. Handb Exp Pharmacol. 2008;181(181):69-97. doi: 10.1007/978-3-540-73259-4_4. Handb Exp Pharmacol. 2008. PMID: 18071942 Free PMC article. Review.
De-Risking Immunotherapy: Report of a Consensus Workshop of the Cancer Immunotherapy Consortium of the Cancer Research Institute.
Mellman I, Hubbard-Lucey VM, Tontonoz MJ, Kalos MD, Chen DS, Allison JP, Drake CG, Levitsky H, Lonberg N, van der Burg SH, Fearon DT, Wherry EJ, Lowy I, Vonderheide RH, Hwu P. Mellman I, et al. Among authors: lonberg n. Cancer Immunol Res. 2016 Apr;4(4):279-88. doi: 10.1158/2326-6066.CIR-16-0045. Cancer Immunol Res. 2016. PMID: 27036972 Review.
52 results